Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: A preliminary study

Neuropsychiatric Disease and Treatment

Volumn 8, Issue , 2012, Pages 537-547

  Bersani, Giuseppe ^a   Bersani, Francesco Saverio ^a,b   Valeriani, Giuseppe ^a   Robiony, Maddalena ^a   Anastasia, Annalisa ^a   Colletti, Chiara ^a,c   Liberati, Damien ^a   Capra, Enrico ^b   Quartini, Adele ^a   Polli, Elisa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Facial Action Coding System; Facial expression; Obsessive compulsive disorder; Schizophrenia

Indexed keywords

ALPRAZOLAM; ARIPIPRAZOLE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; ESCITALOPRAM; FLUVOXAMINE; GABAPENTIN; LITHIUM; LORAZEPAM; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; ZOLPIDEM;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CODING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EMOTIONAL DISORDER; EMOTIONALITY; FACIAL ACTION CODING SYSTEM; FACIAL EXPRESSION; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; VISUAL STIMULATION; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84881303585     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S37174     Document Type: Article

References (46)

1. Duchenne de Boulogne GB. The Mechanism of Human Facial Expression. New York, NY: Cambridge University Press; 1990.
2. Schilbach L, Eickhoff SB, Mojzisch A, Vogeley K. What's in a smile? Neural correlates of facial embodiment during social interaction. Soc Neurosci. 2008;3:37-50.
3. Gosselin P, Kirouac G. Decoding facial emotional prototypes. Can J Exp Psychol. 1995;49:313-329.
4. Kohler C, Turner T, Bilker W, et al. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry. 2003;160:1768-1774.
5. Lawrence N, Williams A, Surguladze S, et al. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry. 2004;55:578-587.
6. Brockmeier B, Ulrich G. Asymmetries of expressive facial movements during experimentally induced positive versus negative mood states: a videoanalytic study. Cogn Emot. 1993;7:393-405.
7. Borod JC, Alpert M, Brozgold A. A preliminary comparison of flat affect schizophrenics and brain-damaged patients on measures of affective processing. J Commun Disord. 1989;22:93-104.
8. Adelmann P, Zajonc R. Facial efference and the experience of emotion. Annu Rev Psychol. 1989;40:249-280.
9. Ekman P, Friesen WV. Facial Action Coding System: A Technique for the Measurement of Facial Movement. Palo Alto, CA: Consulting Psychologists Press; 1978.
10. Edwards J, Jackson HJ, Pattison PE. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev. 2002;22:789-832.
11. Krause R, Steimer E, Sanger-Alt C, Wagner G. Facial expression of schizophrenic patients and their interaction partners. Psychiatry. 1989;52:1-12.
12. Myin-Germeys I, Delespaul PA, de Vries MW. Schizophrenia patients are more emotionally active than is assumed based on their behavior. Schizophr Bull. 2000;26:847-854.
13. Polli E, Bersani FS, De Rose C, et al. Facial Action Coding System (FACS): an instrument for the objective evaluation of facial expression and its potential applications to the study of schizophrenia. Riv Psichiatr. 2012;47:126-138. Italian.
14. Schaefer KL, Baumann J, Rich BA, et al. Perception of facial emotion in adults with bipolar or unipolar depression and controls. J Psychiatr Res. 2010;44:1229-1235.
15. Schneider F, Fus I, Friedrich J, Heimann H, Himer W. Mobility of mimic in unmedicated schizophrenic patients. Zeitschrift fuer Klinische Psychologie. 1992;21:352-360. German.
16. Gaebel W, Wolwer W. Facial expressivity in the course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 2004;254: 335-342.
17. Falkenberg I, Bartels M, Wild B. Keep smiling! Facial reactions to emotional stimuli and their relationship to emotional contagion in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2008; 258:245-253.
18. Ellgring H, Gaebel W. Facial expression in schizophrenic patients. In: Beigel A, Lopez Ibor JJ, Costa e Silva JA, editors. Past, Present, and Future of Psychiatry. London, UK: World Scientific; 1995:1.
19. Aghevli MA, Blanchard JJ, Horan WP. The expression and experience of emotion in schizophrenia: a study of social interactions. Psychiatry Res. 2003;119:261-270.
20. Dworkin R, Clark S, Amador X, Gorman J. Does affective blunting in schizophrenia reflect affective deficit or neuromotor dysfunction. Schizophr Res. 1996;20:301-306.
21. Schneider F, Ellgring H, Friedrich J, et al. The effects of neuroleptics on facial action in schizophrenic patients. Pharmacopsychiatry. 1992;25:233-239.
22. Kohler CG, Martin EA, Stolar N, et al. Static posed and evoked facial expressions of emotions in schizophrenia. Schizophr Res. 2008;105:49-60.
23. Blanchard JJ, Sayers SL, Collins LM, Bellack AS. Affectivity in the problem solving interactions of schizophrenia patients and their family members. Schizophr Res. 2004;69:105-117.
24. Simons G, Ellgring JH, Beck-Dossler K, Gaebel W, Wölwer W. Facial expression in male and female schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. 2010;260:267-276.
25. Mergl R, Vogel M, Mavrogiorgou P, et al. Kinematical analysis of emotionally induced facial expressions in patients with obsessive-compulsive disorder. Psychol Med. 2003;33:1453-1462.
26. Philippot P. Inducing and assessing differentiated emotion-feeling states in the laboratory. Cogn Emot. 1993;7:171-193.
27. Gross JJ, Levenson RW. Emotion elicitation using films. Cogn Emot. 1995;9:87-108.
28. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383-402.
29. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
30. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
31. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
32. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13: 261-276.
33. Ekman P, Friesen W, Hager JC. Facial Action Coding System Investigator's Guide. Palo Alto, CA: Consulting Psychologists Press; 1978.
34. Doop ML, Park S. Facial expression and face orientation processing in schizophrenia. Psychiatry Res. 2009;170:103-107.
35. Bozikas VP, Kosmidis MH, Giannakou M, Saitis M, Fokas K, Garyfallos G. Emotion perception in obsessive-compulsive disorder. J Int Neuropsychol Soc. 2009;15:148-153.
36. Aigner M, Sachs G, Bruckmüller E, et al. Cognitive and emotion recognition deficits in obsessive-compulsive disorder. Psychiatry Res. 2007;149:121-128.
37. Thomas N, Tharyan P. Soft neurological signs in drug-free people with schizophrenia with and without obsessive-compulsive symptoms. J Neuropsychiatry Clin Neurosci. 2011;23:68-73.
38. Bersani G, Clemente R, Gherardelli S, Bersani FS, Manuali G. Obstetric complications and neurological soft signs in male patients with schizophrenia. Acta Neuropsychiatr. 2012;24(6):344-348.
39. Guz H, Aygun D. Neurological soft signs in obsessive-compulsive disorder. Neurol India. 2004;52:72-75.
40. Geller DA, Wieland N, Carey K, et al. Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2008;18:373-379.
41. Attademo L, De Giorgio G, Quartesan R, Moretti P. Schizophrenia and obsessive-compulsive disorder: from comorbidity to schizo-obsessive disorder. Riv Psichiatr. 2012;47:106-115.
42. Rocca CC, Heuvel E, Caetano SC, Lafer B. Facial emotion recognition in bipolar disorder: a critical review. Rev Bras Psiquiatr. 2009;31: 171-180.
43. Bersani FS, Capra E, Minichino A, et al. Factors affecting interindividual differences in clozapine response: a review and case report. Hum Psychopharmacol. 2011;26:177-187.
44. Buchanan RW, Javitt DC, Marder SR, et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairment. Am J Psychiatry. 2007;164:1593-1602.
45. Liberman J, Stroup T, McEvoy J, et al. Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators: effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
46. Flagstad P, Glenthøj BY, Didriksen M. Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology. 2005;30: 250-260.